Results
6
Smaller, under-the-radar companies, backed by insider buying, presenting a compelling opportunity for investors seeking undervalued gems.
6 companies
Integral Diagnostics
Market Cap: AU$828.7m
A healthcare services company, engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand.
IDX
AU$2.23
7D
4.2%
1Y
-5.9%
Tristel
Market Cap: UK£151.7m
Develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally.
TSTL
UK£3.18
7D
17.8%
1Y
-32.3%
Tandem Diabetes Care
Market Cap: US$1.1b
Designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally.
TNDM
US$17.03
7D
1.1%
1Y
-46.5%
Claritev
Market Cap: US$329.1m
Provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States.
CTEV
US$20.73
7D
5.1%
1Y
-32.7%
EL.En
Market Cap: €632.2m
Engages in the research, development, production, sale, and distribution of laser solutions in Italy, rest of Europe, and internationally.
ELN
€7.89
7D
5.0%
1Y
-34.7%
EKF Diagnostics Holdings
Market Cap: UK£97.7m
Engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally.
EKF
UK£0.22
7D
2.9%
1Y
-24.1%